MedPath

Is Barium Enema an Adequate Diagnostic Test for Patients With Positive FOBT?

Not Applicable
Completed
Conditions
Colorectal Cancer
Interventions
Procedure: Double-contrast Barium enema, colonoscopy
Registration Number
NCT00619814
Lead Sponsor
VA Caribbean Healthcare System
Brief Summary

The research protocol aim is to compare diagnostic tools for the proper evaluation of patient with fecal occult blood test positive (FOBT +), a routine screening test for colorecatl carcinoma. The purpose of this study is to determine if Double Contrast Barium Enema (DCBE), a specialized radiographic exam of the colon, is a reasonable alternative for the evaluation of patients with positive fecal occult blood as compared to colonoscopy, which is considered the best evaluation method. Colonoscopy involves the direct visualization of the colon using a flexible instrument. This permits the removal of polyps and to obtain biopsies. It involves additional risks, discomfort and costs. In fact the DCBE is the experimental procedure in this protocol.

Additional aims of this study are: to determine the localization, number, size and pathologic characteristics, if applicable, of findings in colonoscopy and/or DCBE and to determine the patient preference between both studies.

This study is limited to those patients 50 years or older who are at average risk for colon cancer and who had a positive fecal occult blood screening test.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Asymptomatic patients older than 50 years of age, with at least one positive FOBT
  • Without history of colon cancer and/or polyps
  • Gross gastrointestinal bleeding or prior colonoscopy or DCBE
  • Who were willing to participate in the study
  • Were included in the investigation.
Exclusion Criteria
  • Patients with poor cardio-respiratory condition
  • Coagulation deficiency, use of anticoagulants or other drugs affecting coagulation
  • Severe renal or liver disease
  • Hospitalized patients and palpable abdominal or rectal mass were excluded from the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Cohort groupDouble-contrast Barium enema, colonoscopyCohort group of asymptomatic patients 50-80 years old with a positive fecal occult blood test done for colorectal cancer screening.
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath